| Serum | Urine | |||||||
---|---|---|---|---|---|---|---|---|---|
Group | Subjects (n) | Positive (n) | Sensitivity n (%) | Specificity n (%) | 95Â % CI | Positive (n) | Sensitivity n (%) | Specificity n (%) | 95Â % CI |
VL | 87 | 85 | 85 (97.70) | na | 91.94–99.72 | 82 | 82 (94.25) | na | 87.10–98.11 |
All controls (EC + NEC + DC + TB) | 81 | 2 | na | 79 (97.53) | 91.36–99.70 | 2 | na | 79 (97.53) | 91.36–99.70 |
EC | 33 | 1 | na | 32 (96.97) | 84.24–99.92 | 1 | na | 32 (96.97) | 84.24–99.92 |
DC | 16 | 1 | na | 15 (93.75) | 69.77–99.84 | 0 | na | 16 (100) | 79.41–100 |
TB | 16 | 0 | na | 16 (100) | 79.41–100 | 1 | na | 15 (93.75) | 69.77–99.84 |
NEC | 16 | 0 | na | 16 (100) | 79.41–100 | 0 | na | 16 (100) | 79.41–100 |